Sirona Biochem Corp (SBM) - Net Assets

Latest as of July 2024: CA$-3.46 Million CAD ≈ $-2.51 Million USD

Based on the latest financial reports, Sirona Biochem Corp (SBM) has net assets worth CA$-3.46 Million CAD (≈ $-2.51 Million USD) as of July 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$809.18K ≈ $585.35K USD) and total liabilities (CA$4.27 Million ≈ $3.09 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Sirona Biochem Corp tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$-3.46 Million
% of Total Assets	-428.09%
Annual Growth Rate	N/A
5-Year Change	-214.7%
10-Year Change	-240.28%
Growth Volatility	388.16

Sirona Biochem Corp - Net Assets Trend (2011–2023)

This chart illustrates how Sirona Biochem Corp's net assets have evolved over time, based on quarterly financial data. See how many days can Sirona Biochem Corp fund operations to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Sirona Biochem Corp (2011–2023)

The table below shows the annual net assets of Sirona Biochem Corp from 2011 to 2023. For live valuation and market cap data, see Sirona Biochem Corp market cap and net worth.

Year	Net Assets	Change
2023-10-31	CA$-2.51 Million ≈ $-1.82 Million	-1270.72%
2022-10-31	CA$214.51K ≈ $155.18K	+321.12%
2021-10-31	CA$-97.02K ≈ $-70.18K	-304.69%
2020-10-31	CA$47.40K ≈ $34.28K	-97.84%
2019-10-31	CA$2.19 Million ≈ $1.58 Million	+196.84%
2018-10-31	CA$-2.26 Million ≈ $-1.64 Million	-10.80%
2017-10-31	CA$-2.04 Million ≈ $-1.48 Million	-230.54%
2016-10-31	CA$1.56 Million ≈ $1.13 Million	-27.17%
2015-10-31	CA$2.15 Million ≈ $1.55 Million	+19.88%
2014-10-31	CA$1.79 Million ≈ $1.30 Million	-16.63%
2013-10-31	CA$2.15 Million ≈ $1.55 Million	+26.25%
2012-10-31	CA$1.70 Million ≈ $1.23 Million	-37.55%
2011-10-31	CA$2.72 Million ≈ $1.97 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Sirona Biochem Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 3875976300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (October 2023)

Component	Amount	Percentage
Other Components	CA$41.39 Million	%
Total Equity	CA$-2.51 Million	100.00%

Sirona Biochem Corp Competitors by Market Cap

The table below lists competitors of Sirona Biochem Corp ranked by their market capitalization.

Company	Market Cap
Reliance Chemotex Industries Limited NSE:RELCHEMQ	$11.24 Million
Dycasa SA BA:DYCA	$11.25 Million
Jet Freight Logistics Limited NSE:JETFREIGHT	$11.26 Million
reAlpha Tech Corp. Common Stock NASDAQ:AIRE	$11.27 Million
InnSuites Hospitality Trust NYSE MKT:IHT	$11.23 Million
CBL International Limited Ordinary Shares NASDAQ:BANL	$11.23 Million
Gurktaler Aktiengesellschaft VI:GAGV	$11.22 Million
AUGA GROUP AB EO 029 F:W9Z	$11.22 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sirona Biochem Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2022 to 2023, total equity changed from 214,515 to -2,511,365, a change of -2,725,880 (-1270.7%).
Net loss of 2,543,190 reduced equity.
Other factors decreased equity by 182,690.

Equity Change Factors (2022 to 2023)

Factor	Impact	Contribution
Net Income	CA$-2.54 Million	-101.27%
Other Changes	CA$-182.69K	-7.27%
Total Change	CA$-	-1270.72%

Book Value vs Market Value Analysis

This analysis compares Sirona Biochem Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-10-31	CA$-0.01	CA$0.06	x
2018-10-31	CA$-0.01	CA$0.06	x
2019-10-31	CA$0.01	CA$0.06	x
2020-10-31	CA$0.00	CA$0.06	x
2021-10-31	CA$0.00	CA$0.06	x
2022-10-31	CA$0.00	CA$0.06	x
2023-10-31	CA$-0.01	CA$0.06	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sirona Biochem Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -7312.43%
• Asset Turnover: 0.03x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-887.57%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	-92.63%	0.00%	0.00x	1.27x	CA$-2.80 Million
2012	-175.48%	0.00%	0.00x	1.57x	CA$-3.15 Million
2013	-124.35%	0.00%	0.00x	1.56x	CA$-2.88 Million
2014	-196.93%	-1697.18%	0.06x	1.91x	CA$-3.70 Million
2015	-170.52%	-45777.34%	0.00x	1.93x	CA$-3.87 Million
2016	-190.30%	-825.18%	0.12x	2.00x	CA$-3.13 Million
2017	0.00%	-81572.68%	0.00x	0.00x	CA$-4.26 Million
2018	0.00%	-99.57%	1.66x	0.00x	CA$-1.05 Million
2019	-207.79%	-3351.61%	0.03x	1.94x	CA$-4.77 Million
2020	-8721.86%	-3910.40%	0.05x	45.09x	CA$-4.14 Million
2021	0.00%	-860.50%	0.21x	0.00x	CA$-2.30 Million
2022	-1658.53%	-529.50%	0.52x	6.02x	CA$-3.58 Million
2023	0.00%	-7312.43%	0.03x	0.00x	CA$-2.29 Million

Industry Comparison

This section compares Sirona Biochem Corp's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $1,525,678
Average return on equity (ROE) among peers: -35.94%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Sirona Biochem Corp (SBM)	CA$-3.46 Million	-92.63%	N/A	$11.23 Million
Appili Therapeutics Inc (APLI)	$-3.27 Million	0.00%	0.00x	$1.39 Million
Aptose Biosciences Inc (APS)	$20.99 Million	-105.95%	0.20x	$4.06 Million
Arch Biopartners Inc (ARCH)	$-4.35 Million	0.00%	0.00x	$29.89 Million
Biomind Labs Inc (BMND)	$-1.43 Million	0.00%	0.00x	$9.70 Million
Cybin Inc (CYBN)	$1.45 Million	0.00%	0.18x	$301.37 Million
Eupraxia Pharmaceuticals Inc (EPRX)	$5.11 Million	-84.55%	0.14x	$335.97 Million
Devonian Health Group Inc (GSD)	$4.13 Million	-44.17%	1.44x	$21.12 Million
Helix BioPharma Corp. (HBP)	$-90.00K	0.00%	0.00x	$78.46 Million
Hemostemix Inc (HEM)	$-7.37 Million	0.00%	0.00x	$6.82 Million
Universal Ibogaine Inc (IBO)	$94.89K	-124.68%	0.23x	$1.13 Million

About Sirona Biochem Corp

V:SBM Canada Biotechnology

Market Cap

$11.23 Million

CA$15.53 Million CAD

Market Cap Rank

#26762 Global

#1114 in Canada

Share Price

CA$0.06

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.06

All Time High

CA$0.66